Stock comparison
LeMaitre Vascular
UFP Technologies
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LMAT
LeMaitre Vascular
Market cap
$2.23B
Sector
Healthcare
UFPT
UFP Technologies
Market cap
$1.77B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LMAT | UFPT | Winner |
|---|---|---|---|
| Warren Buffett | 77B | 64C | LMAT |
| Benjamin Graham | 89A | 79B | LMAT |
| Philip Fisher | 81C | 64C | LMAT |
| Peter Lynch | 67B | 62C | LMAT |
| Joel Greenblatt | 56D | 43D | LMAT |
| Charlie Munger | 68D | 50C | LMAT |
| Terry Smith | 69D | 52D | LMAT |
Side-by-side metrics
| Metric | LMAT | UFPT |
|---|---|---|
| Market cap | $2.23B | $1.77B |
| P/E (TTM) | 37.1x | 24.4x |
| EV/EBIT | 36.6x | 19.7x |
| ROIC (TTM) | 9.43% | 12.31% |
| Gross margin | 72.39% | 28.35% |
| Net margin | 24.35% | 11.27% |
| Revenue CAGR 5y | 12.75% | 30.74% |
| EPS CAGR 5y | 19.04% | 43.19% |
| Debt / Equity | 0.5x | 0.4x |
| Dividend yield | 0.84% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LMAT leads on
- Dividend yield0.84%vs 0.0%+100%
- Gross margin72.39%vs 28.35%+61%
- Net margin24.35%vs 11.27%+54%
- Market cap$2.23Bvs $1.77B+21%
UFPT leads on
- Revenue CAGR 5y30.74%vs 12.75%+59%
- EPS CAGR 5y43.19%vs 19.04%+56%
- EV/EBIT19.7xvs 36.6x+46%
- P/E (TTM)24.4xvs 37.1x+34%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.